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Summary: CDC continues to receive new reports of infections with Shigella strains that are not 
susceptible to ciprofloxacin and/or azithromycin, the antimicrobial agents most commonly used to treat 
shigellosis. Most cases have been reported among gay, bisexual, and other men who have sex with men 
(collectively referred to as MSM) in Illinois, Minnesota, and Montana and among international travelers, 
but cases are also occurring among other populations. Shigellosis is very contagious and can spread 
quickly through communities and across different segments of the population.   
 
CDC recommends meticulous handwashing and other hygiene practices to prevent shigellosis and 
encourages patients with symptoms of shigellosis such as diarrhea and fever to visit a healthcare 
provider. Clinicians should obtain stool cultures from patients suspected of having shigellosis, counsel 
patients about shigellosis prevention, and, when treatment is required, select drugs based on 
antimicrobial susceptibility test results.  
 
This Health Alert Network (HAN) Advisory provides the following: 
 Information about the current status of the outbreaks; 
 Recommendations for clinical management, counseling, and follow-up of exposed patients and 
their contacts; 
 Recommendations on general prevention methods for the public, childcare centers, MSM, and 
international travelers; 
 Information about testing and interpretation of azithromycin susceptibility among shigellae; and 
 Information about revisions to CDC's Shigella website on shigellosis prevention among MSM. 
Background 
Recent Outbreaks of Multidrug-Resistant Shigella sonnei Infections  
1. Extremely drug-resistant (XDR) shigellosis: As of May 7, 2015, five confirmed cases of XDR 
shigellosis were identified with onset dates from September 7, 2014 through April 4, 2015, in 
Illinois and Montana residents. The isolates were tested by CDC’s National Antimicrobial 
Resistance Monitoring System (NARMS) and were resistant to ampicillin, ciprofloxacin, nalidixic 
acid, streptomycin, sulfisoxazole, tetracycline, and trimethoprim/sulphamethoxazole; had 
azithromycin minimum inhibitory concentrations >16 µg/ml; and harbored macrolide resistance 
genes mphA and ermB. Of the five cases, three self-identified as MSM and two are known to 
have experienced >14 days of diarrhea. Additionally, in March 2015, a Colorado resident who 
self-identified as MSM was infected with S. sonnei that was resistant to ciprofloxacin, nalidixic 
acid, and trimethoprim/sulphamethoxazole, and had azithromycin minimum inhibitory 
concentrations >16 µg/ml. All six of these cases yielded a pulsed-field gel electrophoresis (PFGE) 
pattern indistinguishable from those associated with an ongoing cluster summarized in 2) below. 
 
2. Ciprofloxacin-resistant shigellosis: From May 2014 through April 2015, 179 cases with one of 
five highly-related PFGE patterns were identified in 34 states and Puerto Rico; approximately half 
of those who provided information reported international travel before illness onset. Ten of the 
cases identified by PulseNet, and another 115 cases without PFGE data, were part of an 
outbreak in San Francisco, California. All San Francisco isolates, and 89% of isolates overall, 
were resistant to ciprofloxacin. Nineteen cases are known to have occurred among MSM, and 
several MSM sub-clusters have been reported throughout the United States. A sub-outbreak in a 
childcare center made 16 people ill. Please see the MMWR report for more information: 
(http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6412a2.htm?s_cid=mm6412a2_e). 
 
3. Shigellosis with decreased susceptibility to azithromycin (DSA):1 MSM in Chicago, Illinois, 
and metropolitan Minneapolis/St. Paul, Minnesota, were involved in an outbreak from May 13 
through December 8, 2014. Twenty-two isolates displayed highly similar PFGE patterns and had 
DSA; two additional isolates had indistinguishable PFGE patterns but did not undergo 
antimicrobial susceptibility testing. All 22 patients were adult males; 15 of 17 with information self-
identified as MSM, and 12 were known to have HIV infection. An additional case with an 
indistinguishable PFGE pattern occurred in an MSM in San Francisco in January 2015, but the 
isolate was not available for azithromycin susceptibility testing. Please see the MMWR report for 
more information: 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6421a7.htm?s_cid=mm6421a7_w  
Figure 1  
 
†DSA, decreased susceptibility to azithromycin.  XDR, resistant to at least ampicillin, 
trimethoprim/sulfamethoxazole, and ciprofloxacin, and with decreased susceptibility to azithromycin 
 
                                                 
1 The term decreased susceptibility to azithromycin, or DSA, is used because clinical breakpoints have not been 
















Week of Shigella isolation
Shigella sonnei infections by isolation date and antimicrobial 
resistance phenotype—United States,








General Prevention Recommendations  
 Always practice good hygiene, such as washing hands with soap before preparing food or 
eating and after using the toilet, and follow the recommendations below. 
 Childcare centers should: 
o Ensure handwashing stations are at the appropriate height for young children, well-
stocked with soap and paper towels, and located near diapering, toilet, food 
preparation, and dining areas.  
o Require handwashing among children and staff upon arrival at the facility, after 
diaper changes and toileting, after outdoor play, before eating, and before departing 
the facility. 
o Follow proper diapering procedures. For more information about this, see: 
http://www.cdc.gov/healthywater/pdf/hygiene/Diapering-procedures-childcare-
508c.PDF  
o Assign separate staff to food preparation and diapering. 
o Avoid providing wading pools or basins of water for sensory play. 
o Exclude children and staff with diarrhea as directed by local ordinances. 
 
 MSM should: 
o Avoid sex while ill or while partners are ill with diarrhea and for a few weeks after 
recovering. 
o Wash hands, genitals, and anus with soap before and after sex. 
o Use barriers such as dental dams and gloves during anal rimming and fisting. 
o Use condoms during anal or oral sex. 
o For more information about Shigella infections among MSM, see 
http://www.cdc.gov/shigella/msm.html.  
o  
 International travelers should: 
o Strictly observe food, water, and hand hygiene precautions. For more information 
about this, see http://www.cdc.gov/shigella/msm.html.  
o Consider taking bismuth subsalicylate (e.g., Pepto-Bismol, Kaopectate) to prevent 
travelers’ diarrhea. 
 
Recommendations for Shigellosis Patients  
Patients infected with Shigella can protect others through the following actions:  
 All patients should: 
o Wash hands with soap after using the toilet. 
o Not prepare food for others while experiencing diarrhea, if possible. 
 Professional food service workers should follow the guidance of their 
local health department about exclusion from and return to work. 
o Not swim for 1 week after recovering from diarrhea. 
 Children in childcare and childcare staff should:  
o Stay home while ill with shigellosis. 
o Follow the guidance of the local health department about return to the childcare 
facility. 
 MSM should: 
o Avoid sex while ill with diarrhea and for a few weeks after recovering. Shigellae 
have been documented in stool for as long as 11 weeks after diarrhea has 
stopped, although most patients are likely to have shigellae in stool for a shorter 
period of time. Avoid sex for a few weeks after recovering or until a convalescent 
stool culture is negative to reduce the likelihood of transmission to sexual 
partners. 
o After resuming sex, protect others by: 
 Washing hands, genitals, and anus with soap before and after sex. 
 Using barriers such as dental dams and gloves during anal rimming and 
fisting. 
 Using condoms during anal and oral sex.  
o For more information about Shigella infections among gay and bisexual men, see 
http://www.cdc.gov/shigella/msm.html.  
Recommendations for Clinicians  
 Obtain stool cultures from patients suspected of having shigellosis.  
 Base treatment for shigellosis, when needed, on the antimicrobial susceptibility profile of 
the individual isolate, or during a local outbreak, that of the outbreak strain. 
 Counsel shigellosis patients about the importance of meticulous handwashing after using 
the toilet, and avoiding activities most likely to transmit the infection to others, such as 
preparing food for others, swimming, group play among young children, and certain 
sexual activities (e.g., anal rimming or fisting). 
 Recommend symptomatic contacts of shigellosis patients, particularly those suspected to 
have a multidrug-resistant strain, seek health care.  
 For shigellosis patients with treatment failure or prolonged diarrhea, obtain follow-up stool 
cultures at short intervals (e.g., semi-weekly) until the patient has a negative culture.  
Shedding of multidrug-resistant shigellae in feces may be prolonged, particularly if the 
patient was treated with an antimicrobial medication to which the isolate was resistant.  
Confirming clearance of shigellae from stool will allow more accurate counseling about 
the timelines appropriate for return to higher-risk activities.   
 
Testing and Interpretation of Azithromycin Susceptibility among Shigellae  
Antimicrobial susceptibility testing guidelines and interpretive criteria for azithromycin and Shigella have 
not been published by clinical laboratory organizations, such as the Clinical and Laboratory Standards 
Institute. CDC’s National Antimicrobial Resistance Monitoring System (NARMS) has developed a protocol 
to test Shigella for susceptibility to azithromycin using the disk diffusion method.  Health department and 
clinical laboratories that wish to use the protocol for epidemiologic purposes may contact Davina 
Campbell at xew9@cdc.gov for more information. 
 
Revisions to CDC's Shigella Website, Including Prevention among MSM  
CDC recently updated the Frequently Asked Questions page on its Shigella website 
(http://www.cdc.gov/shigella/general-information.html). In addition, CDC developed new guidance and a 
fact sheet on prevention of shigellosis among MSM (http://www.cdc.gov/shigella/msm.html). 
 
For More Information  
 For more information on Shigella, see http://www.cdc.gov/shigella/index.html or contact 
Jacqueline Hurd at xyf2@cdc.gov.  
 
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and injuries; enhances health decisions by providing credible information on critical health 
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